These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9175188)

  • 1. Influence of retroactive disability payments on recipients' compliance with substance abuse treatment.
    Satel S; Reuter P; Hartley D; Rosenheck R; Mintz J
    Psychiatr Serv; 1997 Jun; 48(6):796-9. PubMed ID: 9175188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability payments and chemical dependence: conflicting values and uncertain effects.
    Rosenheck R
    Psychiatr Serv; 1997 Jun; 48(6):789-91. PubMed ID: 9175186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of public support payments to substance abuse among homeless veterans with mental illness.
    Frisman LK; Rosenheck R
    Psychiatr Serv; 1997 Jun; 48(6):792-5. PubMed ID: 9175187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of representative payees on substance use by homeless persons with serious mental illness.
    Rosenheck R; Lam J; Randolph F
    Psychiatr Serv; 1997 Jun; 48(6):800-6. PubMed ID: 9175189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Representative payee practices of community mental health centers in Washington State.
    Ries RK; Dyck DG
    Psychiatr Serv; 1997 Jun; 48(6):811-4. PubMed ID: 9175191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment expectations in clients: impact on retention and effectiveness in outpatient substance abuse treatment.
    Kuusisto K; Knuuttila V; Saarnio P
    Behav Cogn Psychother; 2011 May; 39(3):257-71. PubMed ID: 21489349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in substance abuse treatment. Role of psychiatric symptom severity.
    Ross HE; Cutler M; Sklar SM
    Am J Addict; 1997; 6(4):293-303. PubMed ID: 9398927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congressional study finds federal disability payments are subsidizing alcohol, drug abuse.
    Hosp Community Psychiatry; 1994 Apr; 45(4):392. PubMed ID: 8020932
    [No Abstract]   [Full Text] [Related]  

  • 10. Street youth in substance abuse treatment: characteristics and treatment compliance.
    Smart RG; Ogborne AC
    Adolescence; 1994; 29(115):733-45. PubMed ID: 7832037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use and assignment of representative payees.
    Rosen MI; Rosenheck R
    Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: a prospective study.
    Ravndal E; Vaglum P
    Acta Psychiatr Scand; 1991 Mar; 83(3):217-22. PubMed ID: 2031467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment.
    Dodge R; Sindelar J; Sinha R
    J Subst Abuse Treat; 2005 Mar; 28(2):189-96. PubMed ID: 15780549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of residential treatment of substance abuse in hospital- and community-based programs.
    Moos RH; King MJ; Patterson MA
    Psychiatr Serv; 1996 Jan; 47(1):68-74. PubMed ID: 8925349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment goals in addiction healthcare: the perspectives of patients and clinicians.
    Joosten EA; De Weert-Van Oene GH; Sensky T; Van Der Staak CP; De Jong CA
    Int J Soc Psychiatry; 2011 May; 57(3):263-76. PubMed ID: 20068024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care.
    Stein B; Orlando M; Sturm R
    Psychiatr Serv; 2000 Feb; 51(2):195-8. PubMed ID: 10655002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplemental Security Income (SSI), Disability Insurance (DI), and substance abusers.
    Gresenz CR; Watkins K; Podus D
    Community Ment Health J; 1998 Aug; 34(4):337-50. PubMed ID: 9693863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of opiate users leaving detoxification treatment against medical advice.
    Kenne DR; Boros AP; Fischbein RL
    J Addict Dis; 2010 Jul; 29(3):383-94. PubMed ID: 20635287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood abuse as a factor in attrition from drug rehabilitation.
    Palmer JA; Palmer LK; Williamson D
    Psychol Rep; 1995 Jun; 76(3 Pt 1):879-82. PubMed ID: 7568605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.